ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PRTC PureTech Health PLC

29.80
0.00 (0.00%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
PureTech Health PLC PRTC NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 29.80 07:00:00
Open Price Low Price High Price Close Price Previous Close
28.74 28.40 28.74 29.80 29.80
more quote information »

Recent News

Date Time Source Heading
14/6/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/6/202403:15BWPureTech Health: Results of Annual General Meeting
07/6/202406:39EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
07/6/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/6/202402:38BWPureTech Health: Result of General Meeting
05/6/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202421:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
30/5/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
30/5/202406:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202422:09BWPureTech Founded Entity Akili Interactive and Virtual..
23/5/202421:00BWPureTech to Present at the Jefferies Global Healthcare..
21/5/202421:05BWPureTech Founded Entity Vedanta Biosciences Enrolls First..
21/5/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/5/202421:03EDGAR2Form SC TO-I - Tender offer statement by Issuer
20/5/202416:00BWPureTech Health: Launch of Proposed $100 Million Tender..
09/5/202421:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
07/5/202421:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
25/4/202419:22BWPureTech Announces Annual Results for Year Ended December..
18/4/202416:00BWPureTech Health: Notice of Results
16/4/202421:00BWPureTech Announces Completion of Enrollment in Phase 2b..
11/4/202421:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
09/4/202416:00BWPureTech Launches Seaport Therapeutics with $100 Million..
19/3/202418:00BWPureTech Proposes $100 Million Capital Return
19/3/202400:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
13/3/202422:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
27/2/202423:00BWPureTech to Present at Two Upcoming Investor Conferences
27/2/202418:00BWPureTech Founded Entity Akili Announces Positive Results..
05/1/202408:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202423:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
23/12/202301:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
20/12/202318:00BWPureTech Year End Update and Outlook for 2024
07/12/202322:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
30/11/202302:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
17/11/202318:00BWPureTech Founded Entity Karuna Therapeutics Announces..
14/11/202318:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
03/11/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202317:00BWPureTech to Present at Two Upcoming Investor Conferences
11/10/202322:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
04/10/202322:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
28/9/202321:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
27/9/202316:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
07/9/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202320:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202316:00BWPureTech Health plc – Half-Year Report
22/8/202316:00BWPureTech Health: Notice of Half-Yearly Results
03/8/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202321:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..
07/7/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/6/202321:00BWPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral..

Your Recent History

Delayed Upgrade Clock